Cargando…
SUN-444 Efficacy and Safety of Dopamine Agonists in Psychiatric Patients Treated with Antipsychotics and Presenting a Macroprolactinoma
Dopamine agonists (DAs), which are used as first line therapy in patients with macroprolactinomas, and antipsychotics have opposite effects on D2 dopamine receptors. In patients with severe psychiatric conditions treated with antipsychotics, the rare occurrence of a macroprolactinoma, particularly w...
Autores principales: | Allard, Lucie, Albarel Loy, Frédérique, Bertherat, Jerome, Caron, Philippe, Cortet-Rudelli, Christine, Courtillot, Carine, Delemer, Brigitte, Jublanc, Christel, Maiter, Dominique, Nunes, Marie-Laure, Raverot, Gerald, Salenave, Sylvie, Sarfati, Julie, Chanson, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552775/ http://dx.doi.org/10.1210/js.2019-SUN-444 |
Ejemplares similares
-
OR17-05 Lysine Demethylase KDM1A And Ectopic Expression Of GIP-Receptor In Somatotropinomas Of Patients With Paradoxical Response To Oral Glucose
por: Chasseloup, Fanny, et al.
Publicado: (2023) -
A Challenging Case of Pituitary Macroprolactinoma During Pregnancy
por: Zainal, Abir, et al.
Publicado: (2021) -
Macroprolactinoma in a Patient With Schizophrenia: A Therapeutic Challenge
por: Voelz, Eduardo, et al.
Publicado: (2021) -
SAT-477 Pituitary Carcinoma Arising from a Macroprolactinoma
por: Gammoh, Emily, et al.
Publicado: (2019) -
SAT-258 Surprising Transformation of a Microprolactinoma to a Macroprolactinoma
por: Athonvarangkul, Diana, et al.
Publicado: (2020)